Long non-coding RNAHOTAIRis an independent prognostic marker for nasopharyngeal carcinoma progression and survival

    loading  Checking for direct PDF access through Ovid


Identification of new nasopharyngeal carcinoma (NPC) biomarkers is of great clinical value for the diagnosis and treatment of NPC.HOTAIR, a cancer-related long non-coding RNA, was tested and its prognostic value for NPC was evaluated. As determined usingin situhybridization (ISH), 91 of 160 (56.87%) paraffin-embedded NPC biopsies showed high expression levels ofHOTAIR(staining index score ≥ 6).HOTAIRwas upregulated in tumors with a large size (P= 0.021), more advanced clinical stage (P= 0.012) and increased lymph node tumor burden (P= 0.005). Quantified using real-time PCR, HOTAIRexpression levels in fresh tissue and paraffin-embedded samples were 5.2 ˜ 48.4-fold higher compared with non-cancer tissue samples. Moreover,HOTAIRexpression levels increased with clinical stage progression, which was consistent with ISH findings in the paraffin-embedded tissue. Most importantly, NPC patients with higherHOTAIRlevels had a poor prognosis for overall survival using univariate and multivariate analysis. In addition,HOTAIRmediated the migration, invasion and proliferation of NPC cellsin vitro.HOTAIRis a potential biomarker for the prognosis of NPC, and dysregulation ofHOTAIRmight play an important role in NPC progression.

    loading  Loading Related Articles